BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3973182)

  • 1. Delayed iodine scanning of the liver: a promising CT technique.
    Phillips VM; Erwin BC; Bernardino ME
    J Comput Assist Tomogr; 1985; 9(2):415-6. PubMed ID: 3973182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of delayed computed tomography of the liver 4 hours after the administration of meglumine diatrizoate].
    Römer T; Hamm B; Nauert C; Felsenberg D; Wolf KJ
    Rontgenpraxis; 1986 Apr; 39(4):127-30. PubMed ID: 3010479
    [No Abstract]   [Full Text] [Related]  

  • 3. Delayed high iodine dose contrast computed tomography: cranial neoplasms.
    Hayman LA; Evans RA; Hinck VC
    Radiology; 1980 Sep; 136(3):677-84. PubMed ID: 7403546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-density evaluation of the liver after iosulamide meglumine: a tissue-specific CT contrast agent.
    Marincek B; Young SW; Enzmann DR
    Invest Radiol; 1982; 17(1):90-4. PubMed ID: 7076441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of urographic and cholegraphic contrast enhanced CT liver scanning.
    Stephenson TF; Chang A; Pandya K; Ona F
    Comput Radiol; 1982; 6(5):257-62. PubMed ID: 7172643
    [No Abstract]   [Full Text] [Related]  

  • 6. CT densities in delayed iodine hepatic scanning.
    Perkerson RB; Erwin BC; Baumgartner BR; Phillips VM; Torres WE; Clements JL; Gedgaudas-McClees K; Bernardino ME
    Radiology; 1985 May; 155(2):445-6. PubMed ID: 3983398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT evaluation of suspected hepatic metastases: comparison of techniques for i.v. contrast enhancement.
    Paushter DM; Zeman RK; Scheibler ML; Choyke PL; Jaffe MH; Clark LR
    AJR Am J Roentgenol; 1989 Feb; 152(2):267-71. PubMed ID: 2783503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast dose in CT scanning.
    Prendes JL
    Arch Neurol; 1981 Jan; 38(1):67-8. PubMed ID: 7458731
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of hepatic metastases in breast cancer: the role of nonenhanced and enhanced CT scanning.
    DuBrow RA; David CL; Libshitz HI; Lorigan JG
    J Comput Assist Tomogr; 1990; 14(3):366-9. PubMed ID: 2335601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic hepatic CT: uniphasic and biphasic contrast medium injection protocols.
    Drop A
    Ann Univ Mariae Curie Sklodowska Med; 1999; 54():195-204. PubMed ID: 11205764
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatic enhancement and metastatic lesion conspicuity on CT scans: influence of intravenous glucagon and oral CT contrast material.
    Warshauer DM; Wehmueller MD; Molina PL; Muller KE; DeLuca MC; Lee JK
    Radiology; 1997 Feb; 202(2):394-8. PubMed ID: 9015064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High contrast enhancement of the liver in CT by repeated doses of contrast medium.
    Rossi P; Rovighi L; Tipaldi L; Bompiani C; Simonetti G
    Eur J Radiol; 1981 May; 1(2):126-31. PubMed ID: 7338235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast enhancement of hepatic tumors in CT: comparison between bolus and infusion techniques.
    Burgener FA; Hamlin DJ
    AJR Am J Roentgenol; 1983 Feb; 140(2):291-5. PubMed ID: 6600346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment of patients requiring oral contrast abdominal computed tomography with antiemetics: a randomized controlled trial of efficacy.
    Garra G; Singer AJ; Bamber D; Chohan J; Troxell R; Thode HC
    Ann Emerg Med; 2009 Apr; 53(4):528-33. PubMed ID: 18640743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral administration of contrast medium for rectal opacification in pelvic computed tomography.
    Mintz MC; Seltzer SE
    J Comput Tomogr; 1984 Jan; 8(1):73-4. PubMed ID: 6692687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental hepatosplenography after the administration of liposomes with verografin].
    Aliiakparov MT; Rozenberg OA; Fomina EV; Loshakova LV; Gubareva AV
    Med Radiol (Mosk); 1981 Nov; 26(11):45-8. PubMed ID: 7321787
    [No Abstract]   [Full Text] [Related]  

  • 17. Patient tolerance to sequential administration of Urografin and Hexabrix.
    Partridge JB
    Br J Radiol; 1985 Mar; 58(687):272. PubMed ID: 4063672
    [No Abstract]   [Full Text] [Related]  

  • 18. Prospective randomized trial of iohexol 350 versus meglumine sodium diatrizoate as an oral contrast agent for abdominopelvic computed tomography.
    Peterson CM; Lin M; Pilgram T; Heiken JP
    J Comput Assist Tomogr; 2011; 35(2):202-5. PubMed ID: 21412090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaphylactoid reaction to oral contrast for computed tomography.
    Seymour CW; Pryor JP; Gupta R; Schwab CW
    J Trauma; 2004 Nov; 57(5):1105-7. PubMed ID: 15580040
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral contrast agents in CT of the abdomen.
    Garrett PR; Meshkov SL; Perlmutter GS
    Radiology; 1984 Nov; 153(2):545-6. PubMed ID: 6484186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.